FB8-32197-74992
3 vaccinations
5 coded responses
18 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Registered in v-safe
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Fatigue or tirednessAdult check-in
- 2021-03-05
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-23
Survey response — day 21, dose 1MedDRA: Fatigue, Pyrexia — Feeling: FairFree text: Vaguely feverish and fatiguedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-31
- 2021-04-07
- 2021-04-14
-
2021-04-21
Survey response — day 28, dose 2MedDRA: Fatigue, Productive cough — Feeling: FairFree text: Productive cough; fatugueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — day 35, dose 2MedDRA: Abdominal discomfort — Feeling: FairFree text: Gi distressMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-06-23
-
2021-09-22
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Colds (several) one with feverMedDRA releases: 2024-11 · check-in free text available
-
2021-09-22
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-23
-
2021-11-25
Dose 3 — Pfizer-BioNTech
-
2022-03-24
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-11-25 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 21, dose 1
Symptoms: Vaguely feverish and fatigued
Release 7 — day 28, dose 2
Symptoms: Productive cough; fatugue
Release 8 — day 35, dose 2
Symptoms: Gi distress
Release 9 — 6 months, dose 2
Symptoms: Colds (several) one with fever
Release 11 — 12 months, dose 2
Symptoms: Covid.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Productive cough | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release